journal
MENU ▼
Read by QxMD icon Read
search

Oncology (Williston Park, NY) | Page 2

journal
https://read.qxmd.com/read/31095719/the-role-of-primary-tumor-treatment-and-metastasis-directed-therapy-in-oligometastatic-prostate-cancer
#21
Abhinav Gupta, Thomas J Pugh, Elaine Lam, Alison D Sheridan, Sameer Nath
No abstract text is available yet for this article.
May 14, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/31095718/fda-approves-two-new-indications-and-dosage-form-for-pembrolizumab
#22
Traci DeVito, Naveed Saleh
No abstract text is available yet for this article.
May 14, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/31095717/state-of-cancer-research-around-the-globe
#23
Mehmet Sitki Copur
Cancer, the second leading cause of death globally, remains a significant challenge for societies, healthcare systems, and affected individuals worldwide. Adding to this challenge are complex disparities in access to and use of cancer care, basic and clinical research, and clinical trials, as well as disparities in cultural beliefs and genetics. To improve cancer treatment, it is essential that cancer investigators, cooperative groups, national research institutions, national governments, competent authorities, ethics committees, and pharmaceutical companies come together to strengthen global collaboration in cancer research...
May 14, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/31095716/evaluating-immunotherapy-in-nonmetastatic-colorectal-cancer
#24
Frank A Sinicrope
No abstract text is available yet for this article.
May 14, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/31095715/non-small-cell-lung-cancer-after-mantle-radiation-a-case-report-and-brief-review
#25
Carlos A Lopez, Emily S Tonorezos
Survivors of childhood and young adult cancer are at risk for developing subsequent malignant neoplasms, including lung cancer. As survival rates in this group continue to improve and patients enter later decades in life, determining the optimal surveillance and counseling strategies with regards to subsequent cancers remains a challenge. In this case report, we present a non-Hodgkin lymphoma survivor who was incidentally found to have non-small-cell lung cancer 30 years after undergoing treatment that included mantle radiation...
May 14, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/31095714/when-surgery-is-not-an-option-in-renal-cell-carcinoma-the-evolving-role-of-stereotactic-body-radiation-therapy
#26
Joseph Miccio, Kimberly Johung
Historically, radiation therapy has played a limited role in the management of renal cell carcinoma because early studies showed that it had no benefit in the neoadjuvant or adjuvant settings. Thus, radiation has typically been employed for only palliation of metastatic sites. As the ability to deliver conformal high-dose-per-fraction radiation became available, studies began to show excellent local control when treating oligometastatic sites of renal cell carcinoma with stereotactic body radiation therapy (SBRT)...
May 14, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/30990570/supporting-data-vs-patient-requests-in-oncology-when-the-two-don-t-coincide
#27
Mehmet Sitki Copur
Relationships between cancer patients and their oncologists flourish in a milieu of trust and goodwill. However, at times cancer patients may express strong preferences for medical tests, treatments, or other interventions that are not beneficial. Actively challenging these requests can be difficult and may threaten the patient-physician relationship. However, failure to discuss why specific diagnostic or therapeutic interventions are not appropriate may be harmful to the patient and lead to inefficient use or overuse of healthcare resources...
April 15, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/30990569/targeted-therapy-for-mutation-driven-metastatic-non-small-cell-lung-cancer-considerations-for-alk-rearranged-tumors
#28
Kathryn F Mileham, Mufti N Ahmad, Edward S Kim
No abstract text is available yet for this article.
April 15, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/30990568/multiple-myeloma-with-extramedullary-disease-a-challenging-clinical-dilemma
#29
Katherinee Morales-Chacón, María T Bourlon, Deborah Martínez-Baños, Jesús Delgado-de-la-Mora, Christianne Bourlon
No abstract text is available yet for this article.
April 15, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/30990567/what-to-do-when-anti-pd-1-therapy-fails-in-patients-with-melanoma
#30
REVIEW
Meghan J Mooradian, Ryan J Sullivan
Monotherapy with immune checkpoint inhibitors, specifically those targeting programmed death 1 (PD-1), has revolutionized the treatment of metastatic melanoma: approximately 40% of patients achieve a partial or complete response, many of which are durable. However, a subset of patients who initially respond to therapy will progress, leaving the majority of patients in need of an effective second-line approach. While some standard therapies exist, there has been robust interest in utilizing targeted immunotherapy combinations in this population to overcome primary or acquired resistance...
April 15, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/30990566/combining-chemotherapy-and-immunotherapy-for-the-treatment-of-triple-negative-breast-cancer
#31
Heather McArthur
No abstract text is available yet for this article.
April 15, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/30990565/recent-clinical-trials-explore-immunotherapies-for-urothelial-carcinoma
#32
Arjun V Balar
No abstract text is available yet for this article.
April 15, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/30990564/novel-targets-and-precision-medicine-for-prostate-cancer-part-2-tumor-profiling-and-personalized-therapy-in-patients-with-castration-resistant-prostate-cancer
#33
REVIEW
Bryden Considine, Daniel P Petrylak
Despite advances in the treatment of castration-resistant prostate cancer (CRPC), options remain limited and non-curative; thus, prostate cancer remains one of the deadliest cancers in men. The discovery of novel therapeutic targets is needed to improve outcomes for men with metastatic CRPC. Precision/personalized medicine creates new opportunities to discover these targets. With an increase in the use of next-generation sequencing and tumor profiling, potentially clinically relevant tumor mutations are being identified...
April 15, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/30990563/regorafenib-for-metastatic-colorectal-cancer-common-toxicities-and-prevention-strategies
#34
Amber Draper
No abstract text is available yet for this article.
April 15, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/30866035/integrating-novel-targets-and-precision-medicine-into-prostate-cancer-care-part-1-the-non-androgen-targetable-pathways-in-castration-resistant-prostate-cancer
#35
REVIEW
Bryden Considine, Daniel P Petrylak
Prostate cancer is the second most common cause of cancer-related death in men. Although the overall survival of patients with metastatic prostate cancer has improved with the addition of second-generation hormone therapy, most men will develop progressive disease, eventually leading to death. Novel therapeutic mechanisms are needed to improve treatments and outcomes in patients with metastatic prostate cancer. Biomarker-driven treatments such as targeted therapies and immuno-oncologic agents are currently under investigation, and may lead to less toxicity and better outcomes for these patients...
March 13, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/30866034/current-treatment-of-esophageal-cancer-and-promising-clinical-trials-underway
#36
Geoffrey Y Ku
No abstract text is available yet for this article.
March 13, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/30866033/a-patient-with-pure-teratoma-of-the-testis-presenting-with-an-anterior-mediastinal-mass
#37
Alexandria M Hertz, Timothy C Brand, Matthew M Banti
No abstract text is available yet for this article.
March 13, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/30866032/new-developments-in-neoadjuvant-therapy-for-lung-cancer
#38
REVIEW
Paul A Bunn, Erin Schenk, Jose Pacheco, Anastasios Dimou
Lung cancer is the leading cause of cancer death in the United States and worldwide. While most patients present with advanced metastatic disease for which a cure is elusive, increased use of spiral CT screening has led to identification of more early-stage patients who can be treated. At the same time, immunotherapy and new targeted therapies have improved survival in advanced disease. These new therapies are now being studied in the neoadjuvant and adjuvant settings to reduce systemic recurrences and improve cure rates...
March 13, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/30866031/newly-diagnosed-glioblastoma-a-review-on-clinical-management
#39
REVIEW
Rimas V Lukas, Derek A Wainwright, Erik Ladomersky, Sean Sachdev, Adam M Sonabend, Roger Stupp
Glioblastoma is an aggressive primary tumor of the central nervous system. This review will focus on clinical developments and management of newly diagnosed disease, including a discussion about the incorporation of molecular features into the classification of glioblastoma. Such advances will continue to shape our thinking about the disease and how to best manage it. With regards to treatment, the role of surgical resection, radiotherapy, chemotherapy, and tumor-treating fields will be presented. Pivotal studies defining our current standard of care will be highlighted, as will key ongoing trials that may influence our management of glioblastoma in the near future...
March 13, 2019: Oncology (Williston Park, NY)
https://read.qxmd.com/read/30866030/management-of-gastrointestinal-toxicities-from-ixazomib-tips-to-curb-nausea-vomiting-diarrhea-and-constipation
#40
Kevin H Hall
No abstract text is available yet for this article.
March 13, 2019: Oncology (Williston Park, NY)
journal
journal
29689
2
3
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"